Valuation: Boston Scientific Corporation

Market Cap 69.46B 60.38B 56.2B 51.6B 97.44B 6,630B 98.95B 662B 260B 3,301B 261B 255B 11,069B P/E 2026 *
17.4x
P/E 2027 * 18.1x
Enterprise Value 78.83B 68.53B 63.78B 58.56B 111B 7,525B 112B 752B 295B 3,746B 296B 290B 12,562B EV / Sales 2026 *
3.69x
EV / Sales 2027 * 3.39x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day+1.59%
1 week+5.60%
1 month+9.49%
3 months-18.89%
6 months-50.04%
Current year-50.99%
1 week 42.55
Extreme 42.55
47.16
1 month 42.2
Extreme 42.2
47.16
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Fiscal year

Chief Financial Officer

5,184 0.0004%
01/03/26 Fiscal year

Controller/Auditor

2,048 0.0001%
19/02/26 Other

Executive/Senior Manager

6,851 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+1.59%+5.60%-55.46%-9.87% 69.46B
-0.43%+1.06%+22.80%+4.67% 213B
-0.61%+1.82%-1.11%-23.56% 137B
+0.10%+4.69%-26.56%+8.92% 125B
-0.98%+4.16%+8.52%+4.87% 49.56B
-0.91%+5.13%-22.07%-30.22% 47.2B
-0.25%-0.14%+20.52%+13.63% 39.08B
-0.79%+0.70%+30.67%+36.60% 37.05B
-2.75%+12.28%-4.63%-12.79% 30.72B
+0.00%+5.67%+99.69%+6.74% 31.03B
Average -0.50%+4.05%+7.24%-0.10% 77.94B
Weighted average by Cap. -0.34%+3.14%+2.33%-1.65%

Financials

2026 *2027 *
Net sales 21.37B 18.57B 17.29B 15.87B 29.97B 2,040B 30.44B 204B 79.98B 1,015B 80.24B 78.48B 3,405B 22.34B 19.42B 18.08B 16.6B 31.35B 2,133B 31.83B 213B 83.64B 1,062B 83.92B 82.07B 3,561B
Net income 3.79B 3.29B 3.07B 2.82B 5.32B 362B 5.4B 36.14B 14.19B 180B 14.23B 13.92B 604B 3.7B 3.21B 2.99B 2.75B 5.19B 353B 5.27B 35.27B 13.84B 176B 13.89B 13.58B 589B
Net Debt 9.37B 8.15B 7.58B 6.96B 13.15B 895B 13.35B 89.39B 35.08B 445B 35.2B 34.43B 1,494B 6.29B 5.47B 5.09B 4.67B 8.82B 600B 8.96B 59.97B 23.54B 299B 23.62B 23.1B 1,002B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
31/07/26 $46.73 +1.59% 18,691,884
30/07/26 $46.00 -0.09% 25,894,477
29/07/26 $46.04 -0.04% 51,286,660
28/07/26 $46.06 +1.21% 26,905,670
27/07/26 $45.51 +2.85% 20,044,682
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
46.73USD
Average target price
62.69USD
Spread / Average Target
+34.15%

Quarterly revenue - Rate of surprise